Chester Mathis is an American chemist who is currently the Distinguished Professor of Radiology at University of Pittsburgh and holds the UPMC Endowed Chair of PET Research.
[2][3][4] He is known for is work with William E. Klunk on a PET radiotracer for imaging amyloid, a protein linked to neurodegenerative diseases including Alzheimer’s.
His efforts led to the creation of a novel category of high-efficacy radiopharmaceutical agents, for example Pittsburgh Compound-B (PiB), which can be used to assess beta-amyloid in the living human brain using PET scanning, and which is a fluorescent analog of thioflavin T.[3] For his work on Alzheimer's disease he has received the Metlife Foundation Award (2004)[5] and the Potamkin Prize (2008).
This article about an American scientist in academia is a stub.
You can help Wikipedia by expanding it.